Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Sixten Körper"'
Autor:
Austin G. Kulasekararaj, Anna-Elina Lehtinen, Cecily Forsyth, Shreyans Gandhi, Morag Griffin, Sixten Körper, Gabor Mikala, Petra Muus, Ulrik Overgaard, Christopher J. Patriquin, Humphrey Pullon, Yu-Min Shen, Ruth Spearing, Jeff Szer, Guillemette de la Borderie, Petra W. Duda, Ramin Farzaneh-Far, Sharan Ragunathan, Camil E. Sayegh, Douangsone D. Vadysirisack, Hubert Schrezenmeier
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/a6d39a02ce5f4b1dae4e88e54d1607c1
Autor:
Eric Toussirot, Daniel Bradshaw, C Ellen van der Schoot, Lise J Estcourt, David J Roberts, Heli Harvala, Pierre Tiberghien, Bart J A Rijnders, Eva Schrezenmeier, Charline Vauchy, Maxime Desmarets, Simone Hoffmann, Antoine Durrbach, Sixten Körper, Gaëlle Brunotte, Thomas Appl, Erhard Seifried, Hubert Schrezenmeier
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction COVID-19 convalescent plasma (CCP) is a possible treatment option for COVID-19. A comprehensive number of clinical trials on CCP efficacy have already been conducted. However, many aspects of CCP treatment still require investigations: i
Externí odkaz:
https://doaj.org/article/47e9ada6780e45709912246d719e6266
Autor:
Alina Seidel, Simone Hoffmann, Bernd Jahrsdörfer, Sixten Körper, Carolin Ludwig, Christiane Vieweg, Dan Albers, Pascal von Maltitz, Rebecca Müller, Ramin Lotfi, Patrick Wuchter, Harald Klüter, Frank Kirchhoff, Michael Schmidt, Jan Münch, Hubert Schrezenmeier
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundRecent data on immune evasion of new SARS-CoV-2 variants raise concerns about the efficacy of antibody-based COVID-19 therapies. Therefore, in this study the in-vitro neutralization capacity against SARS-CoV-2 variant B.1 and the Omicron su
Externí odkaz:
https://doaj.org/article/421634f4916d4fde9d8b1c1537f0b244
Autor:
Sixten Körper, Beate Grüner, Daniel Zickler, Thomas Wiesmann, Patrick Wuchter, Rainer Blasczyk, Kai Zacharowski, Peter Spieth, Torsten Tonn, Peter Rosenberger, Gregor Paul, Jan Pilch, Joachim Schwäble, Tamam Bakchoul, Thomas Thiele, Julian Knörlein, Matthias M. Dollinger, Jörg Krebs, Martin Bentz, Victor M. Corman, Dzenan Kilalic, Gerlinde Schmidtke-Schrezenmeier, Philipp M. Lepper, Lucas Ernst, Hinnerk Wulf, Alexandra Ulrich, Manfred Weiss, Jan Matthias Kruse, Thomas Burkhardt, Rebecca Müller, Harald Klüter, Michael Schmidt, Bernd Jahrsdörfer, Ramin Lotfi, Markus Rojewski, Thomas Appl, Benjamin Mayer, Philipp Schnecko, Erhard Seifried, Hubert Schrezenmeier
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 24 (2022)
BACKGROUND Results of many randomized trials on COVID-19 convalescent plasma (CCP) have been reported, but information on long-term outcome after CCP treatment is limited. The objectives of this extended observation of the randomized CAPSID trial are
Externí odkaz:
https://doaj.org/article/f215c564e7e54be8bf0fb4d93dce1301
Autor:
Chrysanthi Tsamadou, Carolin Ludwig, Judith Scholz, Matthias Proffen, Janina Hägele, Immanuel Rode, Sixten Körper, Dorit Fabricius, Bernd Jahrsdörfer, Christine Neuchel, Elisa Amann, Hubert Schrezenmeier, Daniel Fürst
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionHumoral immunity after SARS-CoV-2 vaccination has been extensively investigated in blood. Aim of this study was to develop an ELISA method in order to determine the prevalence of IgG and IgA SARS-CoV-2 domain 1 spike-protein (S) specific
Externí odkaz:
https://doaj.org/article/d8d8f5e787164eeb98a2fe0559ade94f
Autor:
Sixten Körper, Eva Vanessa Schrezenmeier, Hector Rincon-Arevalo, Beate Grüner, Daniel Zickler, Manfred Weiss, Thomas Wiesmann, Kai Zacharowski, Johannes Kalbhenn, Martin Bentz, Matthias M. Dollinger, Gregor Paul, Philipp M. Lepper, Lucas Ernst, Hinnerk Wulf, Sebastian Zinn, Thomas Appl, Bernd Jahrsdörfer, Markus Rojewski, Ramin Lotfi, Thomas Dörner, Bettina Jungwirth, Erhard Seifried, Daniel Fürst, Hubert Schrezenmeier
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectivesTo determine the profile of cytokines in patients with severe COVID-19 who were enrolled in a trial of COVID-19 convalescent plasma (CCP).MethodsPatients were randomized to receive standard treatment and 3 CCP units or standard treatment al
Externí odkaz:
https://doaj.org/article/90c74bae414e4409b259d386525152c1
Autor:
Bernd Jahrsdörfer, Matthias Proffen, Judith Scholz, Janina Hägele, Carolin Ludwig, Christiane Vieweg, Aline Grempels, Dorit Fabricius, Ramin Lotfi, Sixten Körper, Guido Adler, Hubert Schrezenmeier
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
In this prospective observational cohort study we analyzed cellular and serological immune response parameters against SARS-CoV-2 and current variants of concern (VOC) in 147 COVID-19-convalescent and 39 COVID-19-naïve individuals before and after B
Externí odkaz:
https://doaj.org/article/9377f00a658f4ac5ac7da426b3fdf220
Autor:
Philipp Steininger, Larissa Herbst, Karl Bihlmaier, Carsten Willam, Sixten Körper, Hubert Schrezenmeier, Harald Klüter, Frederick Pfister, Kerstin Amann, Sabrina Weiss, Detlev H. Krüger, Robert Zimmermann, Klaus Korn, Jörg Hofmann, Thomas Harrer
Publikováno v:
Microorganisms, Vol 11, Iss 2, p 283 (2023)
Puumala hantavirus (PUUV) infections usually show a mild or moderate clinical course, but may sometimes also lead to life-threatening disease. Here, we report on a 60-year-old female patient with common variable immunodeficiency (CVID) who developed
Externí odkaz:
https://doaj.org/article/8c3910faef0a498b84b0087fc53d95dd
Autor:
Bernd Jahrsdörfer, Dorit Fabricius, Judith Scholz, Carolin Ludwig, Aline Grempels, Ramin Lotfi, Sixten Körper, Guido Adler, Hubert Schrezenmeier
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Elderly residents of long-term care facilities (LTCFs) have long been underrepresented in studies on vaccine efficacy, particularly in light of currently emerging variants of concern (VOCs). In this prospective observational cohort study, we analyzed
Externí odkaz:
https://doaj.org/article/f947ae975c6f4b079b93c786656eda79
Autor:
Dorit Fabricius, Carolin Ludwig, Judith Scholz, Immanuel Rode, Chrysanthi Tsamadou, Eva-Maria Jacobsen, Martina Winkelmann, Aline Grempels, Ramin Lotfi, Aleš Janda, Sixten Körper, Guido Adler, Klaus-Michael Debatin, Hubert Schrezenmeier, Bernd Jahrsdörfer
Publikováno v:
Vaccines, Vol 9, Iss 8, p 918 (2021)
To identify the most efficient methods of immunological protection against SARS-CoV-2, including the currently most widespread variants of concern (VOCs)—B.1.1.7, B.1.351 and P.1—a simultaneous side-by-side-comparison of available vaccination reg
Externí odkaz:
https://doaj.org/article/b34f0c5ef6774f098e7f53ae0cb15acf